Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hinton

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Schizophrenia Bulletin Open|May 25, 2026
Do Obsessive-Compulsive Symptoms Increase the Risk of Developing Psychosis? A Systematic Review and Meta-analysisWilliam Hinton, Marco Vivolo, Emma Jimenez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2020
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?William Hinton, Michael Feher, Neil Munro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 2, 2018
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study ProtocolWilliam Hinton, Michael Feher, Neil Munro, et al.
Journal of Innovation in Health Informatics|June 28, 2016
Commentary: A lack of a comparator group makes it hard to be sure whether computerised medical record system implementation achieved a better or worse outcomeSimon De Lusignan, John Williams, William Hinton, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 2, 2019
How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study ProtocolWilliam Hinton, Michael D Feher, Neil Munro, et al.
Diabetes, Obesity & Metabolism|March 23, 2019
Real-world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice networkWilliam Hinton, Michael Feher, Neil Munro, et al.
Primary Care Diabetes|June 27, 2017
The association between diabetes, level of glycaemic control and eye infection: Cohort database studyAbdus Samad Ansari, Simon de Lusignan, William Hinton, et al.
Cardiovascular Diabetology|June 29, 2021
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosisWilliam Hinton, Michael D Feher, Neil Munro, et al.
Studies in Health Technology and Informatics|October 12, 2018
Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMsHarshana Liyanage, Siaw-Teng Liaw, Jitendra Jonnagaddala, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2018
A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational StudyAndrew McGovern, William Hinton, Silvio Calderara, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Schizophrenia Bulletin Open|May 25, 2026
Do Obsessive-Compulsive Symptoms Increase the Risk of Developing Psychosis? A Systematic Review and Meta-analysisWilliam Hinton, Marco Vivolo, Emma Jimenez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2020
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?William Hinton, Michael Feher, Neil Munro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 2, 2018
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study ProtocolWilliam Hinton, Michael Feher, Neil Munro, et al.
Journal of Innovation in Health Informatics|June 28, 2016
Commentary: A lack of a comparator group makes it hard to be sure whether computerised medical record system implementation achieved a better or worse outcomeSimon De Lusignan, John Williams, William Hinton, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 2, 2019
How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study ProtocolWilliam Hinton, Michael D Feher, Neil Munro, et al.
Diabetes, Obesity & Metabolism|March 23, 2019
Real-world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice networkWilliam Hinton, Michael Feher, Neil Munro, et al.
Primary Care Diabetes|June 27, 2017
The association between diabetes, level of glycaemic control and eye infection: Cohort database studyAbdus Samad Ansari, Simon de Lusignan, William Hinton, et al.
Cardiovascular Diabetology|June 29, 2021
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosisWilliam Hinton, Michael D Feher, Neil Munro, et al.
Studies in Health Technology and Informatics|October 12, 2018
Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMsHarshana Liyanage, Siaw-Teng Liaw, Jitendra Jonnagaddala, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2018
A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational StudyAndrew McGovern, William Hinton, Silvio Calderara, et al.
Pageof 6